Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone Therapy
- 1 September 2023
- journal article
- editorial
- Published by Elsevier BV in European Urology
- Vol. 84 (3), 257-259
- https://doi.org/10.1016/j.eururo.2023.05.012
Abstract
No abstract availableFunding Information
- NIH
This publication has 10 references indexed in Scilit:
- Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective StudyEuropean Urology Oncology, 2023
- LBA64 Duration of androgen suppression with post-operative radiotherapy (DADSPORT): A collaborative meta-analysis of aggregate dataAnnals of Oncology, 2022
- LBA9 Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031)Annals of Oncology, 2022
- High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP ConsortiumEuropean Urology, 2022
- Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trialAnnals of Oncology, 2022
- The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trialThe Lancet, 2022
- Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 TrialEuropean Urology, 2021
- 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trialThe Lancet, 2021
- Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate CancerJAMA Oncology, 2021
- Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trialThe Lancet Oncology, 2019